Role of lung biopsy in patients undergoing a modified Fontan procedure
- PMID: 2308363
Role of lung biopsy in patients undergoing a modified Fontan procedure
Abstract
Fifty-six patients undergoing a modified Fontan procedure from 1977 to 1985 had lung tissue available from the perioperative period (n = 51) or recent palliative procedure (n = 5) (37 biopsy, 12 autopsy, 7 biopsy and autopsy). Twenty-six patients had tricuspid atresia, and 30 had other causes of functional univentricular heart. Pulmonary arterial structure was classified by both the Heath-Edwards and morphometric scales. Biopsy and autopsy grades were identical except for a minor difference in Heath-Edwards scale in one case. Elevated preoperative mean pulmonary artery pressure (greater than 15 mm Hg) was associated with medial hypertrophy (p = 0.04), although six patients with normal pulmonary artery pressure had medial hypertrophy and six patients with mean pulmonary artery pressure greater than 15 mm Hg did not have medial hypertrophy. Medial hypertrophy was a possible risk factor in patients with univentricular heart: Patients with medial hypertrophy had a ninefold greater risk of death (p = 0.08). Controlling for confounding variables did not alter this result (0.06 less than or equal to p less than or equal to 0.10). Medial hypertrophy was not a risk factor for death in patients with tricuspid atresia: Four had this feature and each survived. Four patients with tricuspid atresia died and none had medial hypertrophy. A mean transpulmonary pressure gradient was measured on the first postoperative day in 45 patients. In patients with medial hypertrophy there was a trend toward a higher gradient (p = 0.13). All patients with medial hypertrophy who had this measurement (n = 9) had a transpulmonary pressure gradient of 7 mm Hg or greater, whereas this was true in only 18 of 36 without medial hypertrophy (p = 0.007). On the basis of an evaluation of medial hypertrophy, we conclude that biopsy does not aid in selection of patients with tricuspid atresia for a Fontan procedure; its role in patients with univentricular heart is uncertain.
Similar articles
-
Long-term results after Fontan procedure and its modifications.J Thorac Cardiovasc Surg. 1986 May;91(5):690-7. J Thorac Cardiovasc Surg. 1986. PMID: 3702478
-
The clinical value and risks of lung biopsy in children with congenital heart disease.J Thorac Cardiovasc Surg. 1990 Mar;99(3):460-8. J Thorac Cardiovasc Surg. 1990. PMID: 2106601
-
Reevaluation of histomorphometric analysis of lung tissue in decision making for better patient selection for fontan-type operations.Ann Thorac Surg. 2004 Oct;78(4):1371-81; discussion 1371-81. doi: 10.1016/j.athoracsur.2004.02.131. Ann Thorac Surg. 2004. PMID: 15464501
-
Morphological findings contributing to a failed Fontan procedure. Twelve-year experience.Circulation. 1990 Nov;82(5 Suppl):IV177-82. Circulation. 1990. PMID: 1699687
-
Surgical experience with the modified Fontan procedure.Circulation. 1987 Sep;76(3 Pt 2):III61-6. Circulation. 1987. PMID: 2441898
Cited by
-
Pulmonary arterial changes in patients dying after a modified Fontan procedure following pulmonary artery banding.Heart Vessels. 1994;9(5):263-8. doi: 10.1007/BF01745107. Heart Vessels. 1994. PMID: 7814303
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical